I Have Taken The Liberty of Re-Writing The Jan News Release
January 26, 2018 / TheNewswire / Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) announces that in response to Health Canada's January 25, 2018 changes to the physical security requirements under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), the Company is conducting a review of the required Confirmation of Readiness submission for its Dorval, Quebec facility. The Company will be evaluating the existing security system and making any adjustments the necessary adjustments to ensure that cost saving opportunities presented by Health Canada's revised requirements are captured.
Management had previously announced an expected January 26th completion date of the Dorval facility (NR December 27, 2017). Matica and RoyalMax Biotechnology Canada Inc. (“RoyalMax”) management are expecting a minor delay due to the reverse engineering of the facility. We expect this delay to create a more efficient and cost effective operating facility, as well as provide a recapture of capital expenditures made at the facility. do not anticipate any undue delays as the Dorval facility has been built to exceed Health Canada requirements. Once these efficiencies have been achieved any adjustments to the facility are completed, management will be submitting the Photographic-Evidence video to Health Canada to request a cultivation license.
Read more at https://www.stockhouse.com/news/press-releases/2018/01/26/matica-to-submit-confirmation-of-readiness-for-dorval-facility#OVZlvDSzcZEPbfwI.99